What is the recommended dosing regimen for a ketamine infusion in an average adult patient without significant cardiac, hepatic, or renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Ketamine Infusion Dosing for Adults

For anesthesia induction in adults, administer ketamine 1-2 mg/kg IV slowly over 60 seconds, or alternatively at 0.5 mg/kg/min; for maintenance anesthesia, use 0.1-0.5 mg/min continuous infusion. 1

Anesthesia Dosing (FDA-Approved)

Induction

  • IV route: 1-4.5 mg/kg administered slowly over 60 seconds

    • Average effective dose: 2 mg/kg produces 5-10 minutes of surgical anesthesia within 30 seconds
    • Alternative: 1-2 mg/kg at infusion rate of 0.5 mg/kg/min
    • Critical: Rapid administration causes respiratory depression and enhanced vasopressor response 1
  • IM route: 6.5-13 mg/kg

    • Dose of 9-13 mg/kg produces surgical anesthesia within 3-4 minutes, lasting 12-25 minutes 1

Maintenance

  • Continuous infusion: 0.1-0.5 mg/min (microdrip technique) maintains general anesthesia in adults 1
  • Repeat increments of one-half to full induction dose as needed 1

Off-Label Analgesic/Sedation Dosing

Low-Dose Continuous Infusion (Perioperative/ICU)

  • Loading dose: 0.5 mg/kg IV bolus 2
  • Continuous infusion: 0.1-0.2 mg/kg/h (maximum 0.4 mg/kg/h) 2
    • Alternative regimen: 15 mg bolus followed by 20 mg/h for acute pain 3
    • ICU dosing: Median 0.11 mcg/kg/h (range 0.06-0.23) demonstrated safety 4

Key finding: Low-dose ketamine (<1.2 mg/kg/h) reduces opioid consumption by approximately 40% without major complications when used up to 48 hours postoperatively 5

Emergency Department Acute Pain

  • Bolus: 15 mg IV
  • Infusion: 20 mg/h for 1 hour 3
    • Provided median pain reduction of 4 points at 10 minutes
    • 85% patient satisfaction with mostly mild side effects

Critical Safety Considerations

Contraindications

  • Absolute: Patients where blood pressure elevation would be dangerous (uncontrolled hypertension, ischemic heart disease, cerebrovascular disease) 6, 1
  • Absolute: Known hypersensitivity to ketamine 1

Preparation Requirements

  • 100 mg/mL concentration must be diluted before IV use - dilute with equal volume of sterile water, normal saline, or D5W 1
  • For maintenance infusions: prepare 1 mg/mL solution by adding 10 mL of 50 mg/mL vial to 500 mL carrier fluid 1
  • Use immediately after dilution 1

Monitoring

  • Continuous vital signs and cardiac monitoring required 1
  • Administer antisialagogue prior to induction due to salivation risk 1
  • Emergency airway equipment must be immediately available 1

Cardiovascular Effects

Ketamine produces dose-dependent increases in heart rate, blood pressure, and cardiac output via sympathetic stimulation 6, 7. However, decreases in blood pressure, arrhythmias, and cardiac decompensation can also occur 1. Avoid in patients with ischemic heart disease or uncontrolled hypertension.

Emergence Reactions

  • Occur in 10-30% of adults (floating sensations, vivid dreams, hallucinations, delirium) 6, 7, 6
  • Mitigation: Co-administer benzodiazepine (e.g., midazolam) to minimize reactions 6, 7, 1
  • Reduce stimulation during recovery period 1

Adjunctive Use

When used as analgesic adjunct rather than sole anesthetic, reduced doses are appropriate. The evidence supports ketamine as opioid-sparing agent without significantly increasing psychotomimetic events when used at low doses 8, 4. Concurrent benzodiazepine administration is acceptable and commonly used 9.

Pediatric Considerations

For children, ketamine 0.75-2.0 mg/kg combined with midazolam 0.05-0.2 mg/kg showed superior safety profile compared to midazolam/meperidine combinations 6, 7, 6. However, avoid use >3 hours in children ≤3 years due to potential long-term cognitive deficits 1.

Common Pitfalls

  1. Never administer 100 mg/mL concentration IV without dilution - causes severe adverse effects 1
  2. Avoid rapid IV push - administer over minimum 60 seconds to prevent respiratory depression 1
  3. Do not use as sole agent for airway procedures - pharyngeal/laryngeal reflexes not adequately suppressed 1
  4. Monitor for genitourinary symptoms with chronic use - case reports of bladder pain with prolonged exposure 1

Related Questions

How should ketamine be prepared and diluted for a continuous infusion?
What are the expected post‑ketamine infusion effects, required monitoring, and recommended management?
How should ketamine be administered as a continuous intravenous infusion for analgesia in adult patients, including indications, dosing, titration, duration, and monitoring?
What are the pharmacokinetic and pharmacodynamic interactions, and monitoring recommendations, when administering an acute dose of ketamine to a typical adult (age 18‑65) without hepatic, renal, or cardiac disease who is on augmentation therapy such as aripiprazole, lithium, or sertraline?
Is continuous ketamine infusion safe for patients on a general medical floor?
In a patient with a focal common bile duct stricture on MRI but no biliary dilatation, what is the recommended initial diagnostic and therapeutic approach?
Which laboratory tests can be used to assess vitamin D and vitamin B12 deficiencies?
What suture size is appropriate for a plantar (bottom of foot) wound?
What is an appropriate body mass index (BMI) for a 68-year-old male who is 75.5 inches (191.8 cm) tall?
What antibiotic should be used to treat a suspected Staphylococcus aureus (including MRSA) infection?
What is the appropriate antihypertensive management for a 56-year-old male with uncontrolled hypertension (158/79 mm Hg), asymptomatic, currently on amlodipine 10 mg daily, chronic kidney disease with eGFR 13 mL/min/1.73 m², and diabetes with hemoglobin A1c 7.2%?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.